1. Home
  2. BNTC vs MVIS Comparison

BNTC vs MVIS Comparison

Compare BNTC & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • MVIS
  • Stock Information
  • Founded
  • BNTC 1995
  • MVIS 1993
  • Country
  • BNTC United States
  • MVIS United States
  • Employees
  • BNTC N/A
  • MVIS N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • MVIS Industrial Machinery/Components
  • Sector
  • BNTC Health Care
  • MVIS Technology
  • Exchange
  • BNTC Nasdaq
  • MVIS Nasdaq
  • Market Cap
  • BNTC 365.1M
  • MVIS 274.2M
  • IPO Year
  • BNTC N/A
  • MVIS 1996
  • Fundamental
  • Price
  • BNTC $13.99
  • MVIS $1.25
  • Analyst Decision
  • BNTC Strong Buy
  • MVIS Strong Buy
  • Analyst Count
  • BNTC 5
  • MVIS 3
  • Target Price
  • BNTC $24.80
  • MVIS $2.50
  • AVG Volume (30 Days)
  • BNTC 38.1K
  • MVIS 3.5M
  • Earning Date
  • BNTC 11-13-2025
  • MVIS 11-06-2025
  • Dividend Yield
  • BNTC N/A
  • MVIS N/A
  • EPS Growth
  • BNTC N/A
  • MVIS N/A
  • EPS
  • BNTC N/A
  • MVIS N/A
  • Revenue
  • BNTC N/A
  • MVIS $2,584,000.00
  • Revenue This Year
  • BNTC N/A
  • MVIS $47.70
  • Revenue Next Year
  • BNTC N/A
  • MVIS $478.91
  • P/E Ratio
  • BNTC N/A
  • MVIS N/A
  • Revenue Growth
  • BNTC N/A
  • MVIS N/A
  • 52 Week Low
  • BNTC $8.20
  • MVIS $0.80
  • 52 Week High
  • BNTC $17.15
  • MVIS $1.95
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 59.33
  • MVIS 66.02
  • Support Level
  • BNTC $13.49
  • MVIS $1.12
  • Resistance Level
  • BNTC $14.16
  • MVIS $1.17
  • Average True Range (ATR)
  • BNTC 0.56
  • MVIS 0.05
  • MACD
  • BNTC -0.01
  • MVIS 0.01
  • Stochastic Oscillator
  • BNTC 79.12
  • MVIS 90.00

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.

Share on Social Networks: